Extensive financial links between the leaders of US medical professional associations and the pharmaceutical industry have raised concerns over independence and integrity. More than $187 million (US$130 million) in industry payments flowed to leaders of over a five year period according to figures published in BMJ. The majority of the industry funding ($150m) was payments ...
Medical association leaders criticised for financial ties to industry
By Michael Woodhead
3 Jun 2020